Get full access for you and your coworkers.
Start a free company trial todayAlready a member? Log in.
More from MedWatch
Novo Nordisk chairman on top wages: "It's a hard balance to strike"
In 2020, Lars Fruergaard Jørgensen was the highest-paid top executive among Denmark's elite companies. It's hard to strike the right balance, says the Novo Nordisk Chair.
EU Commission initiates formal investigation of Teva
Suspicions of patent maneuvers and smear campaigns against competitors lead the EU Commission to scrutinize pharmaceutical company Teva.
Novo Nordisk chair foresees pressure on pharmaceutical industry
Chair of the Novo Nordisk Board Helge Lund thinks tax payers will be paying a large bill for the Covid-19 crisis. He also expects an additional pressure to fall on the pharmaceutical industry in future years.
Denmark, Israel and Austria to look into the possibility of a joint vaccine production
Denmark wishes to establish a Covid-19 research fund with Israel and Austria and explore the possibility of a joint vaccine production with the two countries, according to the parties at a press conference.
Top news from MedWatch this week
Miss anything?
QC Manager Drug Substance for Product Supply – Ascendis Pharma 
Associate Director Medical Science – Orphazyme 
Sales and Business Development Manager @Bioneer 
Medical Affairs Director – Ascelia Pharma 
Regulatory Affairs Life Cycle Associate 
Associate Director, Clinical Systems, Gensense Analytics & Visualizations - Genmab 
Alliance Manager, Business Development Department - Y-mAbs Therapeutics 
Pharmacovigilance Manager - Vaccibody 
Regulatory Affairs Manager – MC2 Therapeutics 
Director CMC, Drug Product - Galecto 
Clinical Trial Administrator - Scandion Oncology 
Merck – Director Market Access 
Business development manager – IWA consulting 
Director of Product Technology, Aligned Bio 
Chemist for pilot facility and process development - ALK 
Senior Regulatory Affairs consultant in medical equipment